Stereotaxis Announces Definitive Agreement to Acquire Robocath
Stereotaxis, a NYSE-listed leader in surgical robotics, entered into a definitive agreement to acquire Robocath, a French innovator in robotic technologies for interventional cardiology and neurointerventions. The acquisition aims to combine complementary robotic technologies to provide an integrated platform for a broad range of endovascular proce…